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Abstract: Origanum onites L. belongs to the Lamiaceae family which is commonly used for symptomatic treatment of the diseases
of the gastrointestinal, endocrine, and respiratory systems in Turkish ethnobotanical studies and public. In this study our aim was to
investigate the physiological effects of O. onites essential oil (OE) on A549 human lung cancer, MIA PaCa human pancreas cancer and
HUVEC human endothelial cell lines. Our findings showed that O. onites OE treatment at all concentrations (4.79–191.6 µg/mL, 24 h)
can inhibit cell proliferation and induce apoptosis in A549 and MIA PaCa cell lines (P < 0.0001). Although ≤19.16 µg/mL OE treatment
for 24 h did not inhibit cell proliferation in the HUVEC cell lines, higher concentrations of OE (≥38.32 µg/mL) significantly inhibited
cell proliferation. Apoptotic cell counts were significantly (P < 0.0001) higher in all cell lines at both incubation times (24 h 56.3 ± 7%,
48 h 53 ± 5% for A549, 24 h 44 ± 7%, 48 h 44.7 ± 7% for MIA PaCa, 24 h 48.7 ± 6%, 48 h 49.3 ± 5% for HUVEC). Migration rates were
decreased significantly (P < 0.0001) (24 h 64 ± 6%, 48 h 67.2 ± 4% for A549, 24 h 49 ± 5%, 48 h 69.35 ± 5% for MIA PaCa, 24 h 47 ± 5%,
48 h 69.6 ± 2% for HUVEC). Based on these results, OE has been shown to have promising anticancer effects.
Key words: Origanum onites, cellular-migration, apoptosis, proliferation, cancer, wound healing

1. Introduction
Origanum L. belongs to the Lamiaceae family. The genus
Origanum includes approximately 70 taxa in the world and
15 of them are endemic to Turkey, represented by 29 species and 32 taxa in Turkey.1,2 The endemic rate of Turkish
Origanum taxa exceeds 44% suggested that this high rate
shows the gene center of Origanum is Turkey. The Turkish names of Origanum onites L. are; Kırkbaş kekik, Tokalı
kekik, Bilya kekik, Arıkekiği, İncir kekiği, Yemiş kekiği
(Bulut and Tuzlaci, 2013; Sargin et al., 2013). O. onites is a
stenoendemic taxon of the eastern Mediterranean area. Its
distribution is not very wide (Vokou et al., 1988). O. onites
is a subshrub plant up to 65 cm. Flowering times are 4–8
months. The habitat is rocky hills and rocky slopes, usually
on limestone, sometimes in partial shade (Ietswaart, 1982).
For centuries, it is known that Turkish people have used
medicinal plants for the treatment of some minor diseases.
O. onites is commonly prescribed as a herbal tea prepared
by infusion technique for symptomatic treatment of stomSadıkoğlu N (2012). Origanum [online]. Website http://www.
bizimbitkiler.org.tr [accessed 04 January 2021].
2
The Plant List (2013). Summary Statistics [online]. Website
http://www.theplantlist.org/1.1/browse/A/Lamiaceae/Origanum/ [accessed 04 January 2021].
1

ach diseases, digestion problems (Bulut and Tuzlaci, 2013),
diabetes, cough, cholesterol, headache, toothache (Polat
and Satil, 2012), tachycardia, gastrointestinal diseases, hypertension, bronchitis, flu, respiratory tract diseases, (Sargin et al., 2013), immunogenic, antiemetic, carminative
(Sağıroğlu et al., 2013) in Turkish ethnobotanical studies.
When the sample obtained from O. onites was investigated by gas chromatography (GC), it was determined
that it has 78.2% carvacrol main component and the other
important components were myrcene (% 0.5), gammaterpinene (% 4.3), linalyl acetate (% 1.0), borneol (% 8.1),
beta pinene (% 1.1), and cineole (% 1.5) (Andoğan et al.,
2002). Recently few studies have investigated the cytotoxic effect of Origanum species such as O. majorana L.
extract on human breast cancer cell line (MCF-7) (Jssim
and Abdul-Halim, 2020) or oregano essential oil from Origanum minutiflorum O. Schwarz & P.H. Davis on NB2a
neuroblastoma cells (Sari et al., 2020). The antimicrobial
effect of O. onites against P. aeruginosa, E. coli, and S. aureus strains were investigated and it was found to have a
strong antimicrobial effect (Andoğan et al., 2002). It has
been reported that cineole (4.3%) and 7-terpinene (1.5%)
of O. onites components did not show antimicrobial activ-
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ity alone (Andoğan et al., 2002). Carvacrol has been reported to act synergistically against various parasitic organisms, with other compounds found in the essential oil
of O. onites (Novato et al., 2015). While the possibility of
carvacrol’s interaction with anticancer drugs is unknown,
the synergistic effect of carvacrol and Cymbopogon citratus
essential oil on breast cancer in female rats was recently
studied (Rojas-Armas et al., 2020).
Anticancer, antiproliferative and apoptotic effects of
essential oil and several extracts from Origanum species
on various cell types including leukemic cell, platelets and
breast adenocarcinoma cells were also reported by others (Abdel-Massih et al., 2010; Al-Kalaldeh et al., 2010).
For example, hepatocellular carcinoma cell line HepG2
has been widely studied in toxicology tests (Özkan and
Erdoğan, 2011). Few studies are investigating the possible
in vitro physiological effects of O. onites. Bostancıoğlu et
al. (2012) proved that O. onites essential oil inhibits proliferation by in vitro in RATEC which are rat adipose tissue
endothelial cells and 5RP7 which are rat embryonic fibroblasts, depending on concentration and time.
The lowest concentration (62.5 µg/mL) tested in
RATEC and 5RP7 cell lines were reported to be nontoxic
for 4 days. They stated that the studied concentrations of
125, 250, and 500 µg/mL OE had a toxic effect on the cancer cell line, 5RP7. In the same study, 24 h IC50 values were
determined as approximately 125 µg/mL in 5RP7 cells
and 250 µg/mL in RATEC cells. In another report, it has
been reported that ethanolic extracts from the O. onites
plant inhibit the growth of breast cancer (MDA-MB231)
and human glioblastoma (U87) cells (Baranauskaite et al.,
2017). Spyridopoulou et al. (2019) detected that O. onites
essential oil in CT26 (IC50 values for 48 h by 71.70 µg/mL
for 72 h by 1.10 µg/mL) and HT-29 (IC50 values for 48 h by
58.00 µg/mL for 72 h by 0.35 µg/mL) cells. Also stated that
growth was inhibited depending on the concentration and
time. According to the results of the study, it was revealed
that human HT-29 cells are more sensitive to OE than murine CT26 cells.
However, the possible effects of OE on other cell types
(such as lung and pancreatic cancer or endothelial cell lines) have not been widely studied. It may have different
effects on different cell types. Before studying its systemic
effect, it should be tested in different cell lines in cell culture studies, which are model systems. For this reason, we
purposed to explore the effect of OE on HUVEC umbilical
vein endothelial, MIA PaCa pancreas cancer, A549 lung
cancer cell lines. With this aim, the viability, apoptotic/necrotic cell ratio, and migration rates of cells treated with
OE were examined. The correlation between the ratio of
apoptotic cells and cellular reactive oxygen species (ROS)
detection was determined.

2. Material and methods
2.1. Cell culture and chemicals
High glucose DMEM (5546; Sigma-Aldrich, St. Louis,
MO, USA) was used for culturing the cell lines below. Pulmonary adenocarcinoma human alveolar epithelial (A549
ATCC CCL-185); human pancreas carcinoma epithelial
cell [MIA PaCa-2 (ATCC CRL-1420)] human umbilical
vein endothelial cell [HUV-EC-C (HUVEC) (ATCC CRL1730)] lines were purchased from ATCC (USA).
P/S (50 U/mL penicillin and 50 μg/mL streptomycin;
Biological Industries, Beit-Haemek, Israel; 03-031-1B),
1% 2 mM L-glutamine (Biological Industries, BI03-0201B) was added to DMEM with %10 FBS (Biowest, Nuaillé, France; S1810-500). 1.5 × 106 cells from each cell line
were seeded into a 10 cm plate and divided 72 h later. O.
onites essential oil was dissolved in 0.1% dimethyl sulfoxide (DMSO) aqueous solution. It was prepared freshly
for each test and filtered and sterilized through a 0.45 μm
membrane filter (Özkan and Erdoğan, 2011). Negative
control (0 µg/mL OE) indicated treatments of cells with
0.1% DMSO (the solvent of OE) containing DMEM.
2.2. Plant material
Aerial parts of O. onites were collected during the flowering stage from Assos (Çanakkale) the northwestern part of
Turkey in July 2015 at altitudes of 500 m. The plant material was confirmed and the voucher specimen was prepared.
Specimens of these vouchers are kept in the Herbarium
(HERA 249) of the Altınbaş University of Pharmacy.
Origanum onites essential oil preparation
The dried and powdered plant material (100 g) was distilled for 3 h using Clevenger type equipment. The essential oil was dried with anhydrous sodium sulfate, filtered
and stored at –20 °C until use in 2016.
Gas chromatography/mass spectrometry (GC/MS)
analysis
The oil was analyzed by gas chromatography (GC) and
gas chromatography/mass spectrometry (GC/MS) techniques using Agilent 7890B system, fitted with a Agilent
DB-wax (60 m × 0.25 mm × 0.25 µm) capillary column.
Detector and injector temperatures were set at 220 °C.
The temperature program for the column was from 70 °C
(15 min), 2 °C/min to 180 °C (5 min), 5 °C/min and then
held at 230 °C (15 min), total 100 min. Helium was used
as a carrier gas at a flow 1.5 mL/min and injection volume
of each sample was 1 μL. Split ratio was adjusted as 40:1.
MS were taken at 70 eV. Mass range was from m/z 35 to
450 (This analysis was performed in Bezmialem University Phytotherapy Education Research and Application
Center-BİTEM, İstanbul, Turkey).
2.3. MTT assay
12 mM stock solution of MTT (3-(4.5-dimethylthiazol2-yl)-2.5-diphenyltetrazolium bromide) (Neofrox 3580
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MTT) was prepared as described by Mosmann (1983).
Cells were seeded into a 96-well plate at a volume of 100 µL
(about 104 cells per well). The MTT assay was performed
as follows: Add 10 µL of 12 mM MTT stock solution for
each well and incubate at 37 °C for 4 h. Only 100 µL of
medium is included as a negative control. After incubating
with MTT for 4 h, remove 75 µL of medium from the well,
and then dissolve formazan crystals in 50 µL of DMSO by
mixing well with a pipette. After incubating for another 10
min at 37 °C, mix the samples briefly again and record the
absorbance at 540 nm.
2.4. Acridine orange/ethidium bromide double staining
Acridine orange/ethidium bromide (AO/EtBr) dual staining technique was performed as described by Liu et al.
(2015). In short, cells were seeded in 96-well plates at a
density of approximately 104 cells/well. After 48 h of incubation with OE, the cells were trypsinized and 10–25 μL
of the cell suspension was transferred to a glass slide. One
microliter of AO/EtBr staining solution was added to the
cell suspension and then the sample was covered with a
coverslip.
Within 20 min after adding AO/EtBr dye (a mixture
containing 100 μg/mL AO and 100 μg/mL EtBr), the cell
morphology was checked under a fluorescence microscope (Carl-Zeiss/Axio Observer 3, Zen 2.3 Blue Edition
software; Carl Zeiss Microscopy, Oberkochen, Germany).
For statistical analysis, at least 200 cells were counted
and the results expressed as the average of at least three
independent experiments. Both live and dead cells were
stained with AO, while ethidium bromide stains only dead
cells that have lost membrane integrity. Living cells were
uniformly green, while early apoptotic cells show green
dots in their nuclei. Late apoptotic cells were stained orange and show nuclear condensation or fragmentation.
Necrotic cells were stained orange, nuclear morphology is
similar to living cells, but chromatin is not concentrated
(Liu et al., 2015).
2.5. Detection of ROS
Reactive oxygen species (ROS) was measured by the fluorescence microscopy method by using a specific probe,
DCF-DA [DCF-DA (D6883) 50mg; Sigma-Aldrich]. Once
the compound enters the cell, it is cleaved by the intracellular esterase and remains in the cell due to the loss of its
hydrophobic part. After being oxidized by ROS, the fluorescein part is not covered and can be detected by a fluorescence microscope. The amount of fluorescence emitted
is related to the amount of ROS in the cell. This method
has been widely used to measure ROS in living cells (Larsen et al., 2002). A549 human lung cancer, MIA PaCa human pancreas cancer, and HUVEC human endothelial cell
lines were used for the determination of reactive oxygen
production. The cells were treated or nontreated (negative
control) with O. onites essential oil at their respective IC50
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doses for 24 h and then trypsinized. H2O2 (0.1 mM and 0.2
mM) treated cells for 24 h were taken as the positive control. Briefly, prepared a stock solution of DCF-DA (20 mM)
in DMSO (dimethyl sulfoxide) and further diluted it with
culture medium to a working concentration of 0.1 mM.
The trypsinized cells were washed with ice-cold 1×PBS
and incubated with 0.1 μM (working solution) DCF-DA
at 37 °C for 20 min. After washing 3 times in cold PBS,
the cells were imaged under a fluorescence microscope
(Carl-Zeiss/Axio viewer 3, Zen 2.3 Blue Edition software).
Fluorescence images were acquired through a single 300
ms exposure and then DIC images of the same field of
view were acquired. Using Zen 2.3 Blue Edition software,
measured the fluorescence intensity of each cell in a 60 ×
60 pixel box, and took the average of at least 100 cells per
cover glass (n = 6) (Jiang et al., 2004).
2.6. In vitro scratch assay
In vitro scratch assay for evaluating migration rates were
carried out according to the protocol described by Liang et
al. (2007): Briefly, scrape the surface of the wells in a 6-well
plate with a 10 µL sterile pipette tip. After gently washing
with the culture medium, take pictures of the scratches
(gap) at different time points (0–15–24 hours) at 10 times
magnification (Carl-Zeiss/Axio Observer 3) under a microscope and use image analysis. The J software and cell
migration rate are calculated by comparing the scratchfree area at 15 and 24 h after injury with the scratch area
at 0 h. The results are expressed as the average of three experiments.
2.7. Statistical analysis
GraphPad (Prism 5) software was used for statistical
analysis. Multiple comparisons were made using Tukey’s
procedure. P < 0.05 was considered statistically significant.
Statistical analysis was performed on the apoptosis index
between each group using an analysis of variance.
3. Results
Results of GC analysis of O. onites OE obtained by steam
distillation are given in Table 1. Carvacrol was found to
be a major component of the oil as 68.071%, and then followed by cymene (11.150%), γ-terpinene (6.177%) and
borneol (2.624%), respectively (Table 1).
Determining the effective concentration that causes the
cell growth inhibitory concentration (IC50) to decrease by
50% is essential for understanding the biological and pharmacological properties of the drug. First, we compared the
proliferation rate of A549 (human lung adenocarcinoma
basal epithelial cells) MIA PaCa (human pancreas carcinoma epithelial cell) and HUVEC (human umbilical vein
endothelial) cell lines to study the IC50 value of O. onites essential oil and its effect on cell viability by MTT assay. For
this target eleven different concentrations (4.79 µg/mL,
9.58 µg/mL, 19.16 µg/mL, 38.32 µg/mL, 47.9 µg/mL, 57.48
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Table 1. Main components of O. onites OE.
Components

Composition (%)

Alpha pinene

1.070

Camphene

0.556

Delta 3-carene

0.114

Myrcene

1.744

Alpha terpinene

1.927

Limonene

0.451

Beta phellandrene

0.170

Gamma terpinene

6.177

Cymene

11.150

Alpha terpinolene

0.334

1-octen-3-ol

0.121

Linalool

0.090

Linalyl acetate

0.127

Caryophyllene

0.747

4-terpineol

1.428

Alpha terpineol

0.220

Borneol

2.624

Beta bisabolene

0.728

Carvone

0.302

Carvacryl acetate

0.147

Caryophyllene oxide

0.367

Spathulenol

0.159

Thymol

0.408

Carvacrol

68.071

Others

0.765

µg/mL, 67.06 µg/mL, 76.64 µg/mL, 86.22 µg/mL, 95.8 µg/
mL, 191.6 µg/mL for A549 and MIA PaCa, 4.79 µg/mL,
9.58 µg/mL, 19.16 µg/mL, 38.32 µg/mL, 47.9 µg/mL, 67.06
µg/mL, 86.22 µg/mL, 95.8 µg/mL, 191.6 µg/mL, 287.4 µg/
mL and 383.2 µg/mL for HUVEC) of O. onites essential
oil according to Sivas and Tomsuk ( 2011) were tested for
24 and 48 h. IC50 values for A549, MIA PaCa and HUVEC
were found as 4.79 µg/mL; 14.37 µg/mL; 67.06 µg/mL for
24 h and 14.37 µg/mL; 1.916 µg/mL; 306.56 µg/mL for 48 h
in turn. Analysis of data obtained from proliferation studies for A549 and MIA PaCa as shown in Figures 1a–1d, all
levels of O. onites essential oil treatment (for 24 and 48 h:
4.79 µg/mL, 9.58 µg/mL, 19.16 µg/mL, 38.32 µg/mL, 47.9
µg/mL, 57.48 µg/mL, 67.06 µg/mL, 76.64 µg/mL, 86.22
µg/mL, 95.8 µg/mL, 191.6 µg/mL) inhibited the proliferation rate of the two test cell lines. Although as shown in
Figures 1e and 1f, ≤19.16 µg/mL OE treatment for 24 h
did not inhibit cell proliferation in the HUVEC cell lines,

higher concentrations of OE (≥38.32 µg/mL) significantly
inhibited cell proliferation. O. onites essential oil’ 4.79 µg/
mL concentration inhibited proliferation rate by 52.5% in
the A549 cell line at 24 h and increased proliferation rate
by 32% at 48 h. However as shown in Figures 1a and 1b,
9.58 µg/mL concentration of OE inhibited significantly
by 54.4% and not significantly 24.4%, 19.16 µg/mL concentration inhibited by 68.8% and 61.1%, 38.32 µg/mL
concentration inhibited by 80.7% and 64.8%, 47.9 µg/mL
concentration inhibited by 80.6% and 75.1%, 57.48 µg/mL
concentration inhibited proliferation rate by 84.9% and
76.8%, 67.06 µg/mL concentration inhibited proliferation
rate by 84.8% and 77.4%, 76.64 µg/mL concentration inhibited proliferation rate by 85.1% and 76.4%, 86.22 µg/
mL concentration inhibited proliferation rate by 87.3%
and 81.5%, 95.8 µg/mL concentration inhibited proliferation rate by 85.8% and 74.2%, 191.6 µg/mL concentration
inhibited proliferation rate by 93.1% and 78.7% in the
A549 cell line at 24 h and 48 h. O. onites essential oil’ 4.79
µg/mL concentration increased proliferation rate by 5.1%
in the MIA PaCa cell line at 24 h and inhibited proliferation rate by 71.4% at 48 h. As shown in Figures 1c and 1d,
9.58 µg/mL concentration of OE inhibited significantly by
22.1% and 80.3%, 19.16 µg/mL concentration inhibited by
56.4% and 94.7%, 38.32 µg/mL concentration inhibited by
71.6% and 92.9%, 47.9 µg/mL concentration inhibited by
90.6% and 87.5%, 57.48 µg/mL concentration inhibits the
rate of proliferation by 91.8% and 98%, 67.06 µg/mL concentration inhibits proliferation rate by 98.1% and 87.9%,
76.64 µg/mL concentration inhibited proliferation rate by
99.2% and 95.6%, 86.22 µg/mL concentration inhibited
proliferation rate by 99.6% and 98.3%, 95.8 µg/mL concentration inhibited proliferation rate by 98.7% and 97.9%,
191.6 µg/mL concentration inhibited proliferation rate by
98.2% and 96% in the MIA PaCa cell line at 24 h and 48
h, while HUVEC cell line seems to be more resistant to O.
onites essential oil treatment. Endothelial cell line to be exposed 20 times higher doses of OE than MIA PaCa, while
respectively 27 times higher doses of OE than A549 in 24
h for inhibitory effect.
As shown in Figures 1e and 1f, O. onites essential oil
treatment has a significant inhibitory effect on the proliferation rate of HUVEC cell line by 39.3% and 5% in the
concentration of 38.32 µg/mL, by 45.4% and 11.9% in the
concentration of 47.9 µg/mL, by 47.8% and 23.3% in the
concentration of 67.06 µg/mL, by 50.1% and 26.5% in the
concentration of 86.22 µg/mL, by 52.5% and 28.7% in the
concentration of 95.8 µg/mL, by 52.7% and 38.6% in the
concentration of 191.6 µg/mL, by 54.3% and 41% in the
concentration of 287.4 µg/mL and by 57.2% and 54.1%
in the concentration of 383.2 µg/mL for 24 and 48 h.
As shown in Figure 1e, the HUVEC cell line seemed to
be resistive to 19.16 µg/mL compared with the untreated
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Figure 1. a–b. A549 lung cancer, c–d. MIA PaCa pancreas cancer, e–f. HUVEC Endothelial cell lines were treated with O. onites essential
oil placed in the incubator for 24 and 48 h. MTT analysis was performed 24 and 48 h after treatment with the specified dose of O. onites,
the relative change percentage of the proliferation rate was compared with the untreated control group, and the statistical significance
was determined by one-way ANOVA and Tukey multiple comparison tests was performed (*,**,*** P < 0.0001, n = 3).

A549 cell line at 24 h. Again, 19.16 µg/mL concentration
increased by 49.4% in the HUVEC cell line at 48 h. The viability of both cells was shown to be significantly reduced
in the presence of OE (P < 0.0001). O. onites essential oil
showed an inhibitory effect on the growth of all tested cell
lines and the effect of essential oil can vary according to
the incubation period or test concentration. Analysis of
data obtained from MTT analysis shows O. onites essential
oil treatment was able to inhibit the proliferation of A549
and MIA PaCa cell lines in a dose-dependent (A549 R2 =
0.9977 and MIA PaCa R2 = 0.9985, P < 0.0001 for 24 h)
(A549 R2 = 0.8937 and MIA PaCaR2 = 0.9650, P < 0.0001,
for 48 h) manner. In contrast to these cancer cell lines, O.
onites essential oil treatment inhibited the proliferation of
the noncancerous HUVEC cells in high doses. Although,
as shown in Figures 1e and 1f, 19.16 µg/mL (24 h) OE treatment did not appear to affect the rate of cell proliferation,
higher doses of OE (≥38.32 µg/mL for 24 h and ≥67.06 µg/
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mL for 48 h) significantly inhibited proliferation of HUVEC cell in a dose-dependent fashion (R2 = 0.9977, P <
0.0001 for 24 h) (R2 = 0.9924, P < 0.0001, for 48 h).
We then compared the changes in the ratio of apoptotic cells with the “acridine orange/ethidium bromide”
double staining protocol. For this reason, the ratio of live
cells, apoptotic cells and necrotic cells when exposed to the
IC50 value of O. onites essential oil for A549, MIA PaCa
and HUVEC were evaluated as 4.79 µg/mL; 14.37 µg/
mL; 67.06 µg/mL for 24 h and 14.37 µg/mL; 1.916 µg/mL;
306.56 µg/mL for 48 h. In the two incubation times, the
number of apoptotic cells in both cells was significantly
higher (P < 0.0001) (24 h 56.3 ± 9%, 48 h 53 ± 5% for A549,
24 h 44 ± 7%, 48 h 44.7 ± 8% for MIA PaCa and 24 h 48.7
± 6%, 48 h 49.3 ± 4% for HUVEC). However, as shown
in Figures 2a–2c, 14.37 µg/mL concentration of O. onites
essential oil significantly increased the number of necrotic
cells of the A549 cell line within 48 h (necrotic cells: 6.7%).
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Figure 2. O. onites Induce apoptosis with IC50 value. a. A549 lung cancer, b. MIA PaCa pancreas cancer, c. HUVEC endothelial cell lines
were treated with IC50 values of Origanum onites essential oil was evaluated as 4.79 µg/mL; 14.37 µg/mL; 67.06 µg/mL for 24 h and 14.37
µg/mL; 1.916 µg/mL; 306.56 µg/mL for 48 h hours in an incubator. AO/EtBr double staining was performed 24 and 48 h after treatment
with the indicated concentrations of the essential oil from O. onites. The percent change in the ratio of apoptotic cells was compared to
the untreated control group and statistical significance was tested using one-way ANOVA followed by Tukey’s multiple comparison test
(*, **, *** P < 0.0001, n = 6).

A549 cells were more sensitive cell line (24-h incubation
A549: apoptotic cells 56.3%, 48-h incubation A549: apoptotic cells 53%) while MIA PaCa cells seemed to be more
resistant to O. onites essential oil than A549 (24-h incubation MIA PaCa: apoptotic cells 44%, 48-h incubation MIA
PaCa: apoptotic cells 44.7%). As shown in Figures 2a-2c,
endothelial cell line needed to expose 14 times higher
doses of OE than A549 in 24 h as IC50 value, while respectively 160 times higher doses of OE than A549 in 48 h as
IC50 value for inhibitory effect (24-h incubation HUVEC:
apoptotic cells 48.7%, 48-h incubation HUVEC: apoptotic
cells 49.3%). In general, the results obtained support the
experimental basis for reporting that O. onites essential oil
leads to cell death mainly through the process of apoptosis.

Representative microscope images from AO/EtBr stained
samples are shown in Figure 3.
Many studies have shown that after treatment with anticancer drugs, ROS can induce apoptosis of various types
of cancer cells (Pelicano et al., 2004). Therefore, we next
investigated whether OE-induced apoptosis is related to
increased ROS levels in A549, MIA PaCa and HUVEC
cells. As shown in Table 2, the correlation between reactive oxygen production induced by O. onites essential oil
treatment and the rate of apoptosis induced by this oil was
determined. For this purpose, as shown in Figure 4, we
tested the effect of IC50 values of O. onites essential oil as
4.79 µg/mL; 14.37 µg/mL; 67.06 µg/mL for 24 h on cells
for the determination of reactive oxygen production rates
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Figure 3. Representative microscope images from AO/EtBr double staining. Magnification: 10× A549 cells (14.37 µg/mL for 48
h). The arrows point to apoptotic cells, the arrowheads point to
live cells and the double arrowheads point to necrotic cells.

was linked to ROS generation. Representative microscope
images from the DCF-DA analysis sample is shown in Figure 5.
Then, we investigated whether O. onites essential oil
treatment can induce changes in cell migration rate. For
this target, as shown in Figures 6 and 7, we tested the effect of IC50 values of O. onites essential oil as 4.79 µg/mL;
14.37 µg/mL; 67.06 µg/mL for 24 h and 14.37 µg/mL; 1.916
µg/mL; 306.56 µg/mL for 48 h on cell migration rates in
A549, MIA PaCa and HUVEC cell lines using in vitro
scratch assay technique. Our research results show that
treatment with O. onites essential oil significantly reduces
(P < 0.0001) the cell migration rate, as shown in Figures
6a and 6b, A549 (24 h 64 ± 6%, 48 h 67 ± 4%), as shown
in Figures 6c and 6d, MIA PaCa (24 h multiplied by 49 ±
2%, 48 h 69 ± 4%), as shown in Figures 6e and 6f, HUVEC
cell line (24 h multiplied by 47 ± 5%, 48 h 70±1%). A representative microscope image of the scratch experiment is
shown in Figure 7.

in A549, MIA PaCa and HUVEC cell lines using the fluorescence microscopy method by using a specific probe,
DCF-DA. Our findings indicated that O. onites essential
oil treatment increased reactive oxygen production significantly (P < 0.0001). ROS production was observed within
24 h of OE treatment in A549, MIA PaCa and HUVEC cell
lines. As shown in Figure 4, O. onites essential oil’ 4.79 µg/
mL concentration produced ROS by 33.12 ± 1.89 intensity
in the A549 cell line, 14.37 µg/mL concentration produced
ROS by 25.88 ± 1.56 intensity in the MIA PaCa cell line,
67.06 µg/mL concentration produced ROS by 28.65 ± 1.32
intensity in the HUVEC cell line at 24 h. These results indicated that the OE induced apoptosis in these cell lines

4. Discussion
Previous studies have shown that environmental factors such as chemical composition of soil, growing season, moisture, temperature, vegetative stage influence the
chemical composition of plant species (Loziene and Venskutonis, 2005). According to Bostancıoğlu et al. (2012);
O. onites EO had carvacrol (64.3%), linalool (13.8%),
ρ-cymene (13.8%), γ-terpinene (7.1%). Andoğan et al.,
(2002) determined that O. onites EO had 78.2% carvacrol
as a main component and the other important components
were borneol (8.1%), γ -terpinene (4.3%), cineole ( 1.5%).
O. onites is commonly prescribed for treatment of stomach
diseases, digestion problems, diabetes, cough, cholesterol,

Table 2. ROS production correlation with apoptotic cell rate was determined as ROS intensity values correlation with apoptotic cell rate
on cell lines.
Cell line

A549

OE IC50
n
concentration
(µg/mL)
4.79
6

ROS intensity

Apoptosis rate

(+) Control

(–) Control

OE IC50

57.65 ± 1.45

10.52 ± 0.8

a,c,*

MIA PaCa 14.37

6

57.06 ± 2.72

4.73 ± 0.62

a,c

HUVEC

6

58.24 ± 0.98

8.24 ± 0.7

a,c,*

67.06

(+) Control

(–) Control

OE IC50

6 ± 1%

b,d,

56.3 ± 7%

97 ± 2%

2.7 ± 2%

b,d

44 ± 7%

28.65 ± 1.32 99 ± 1%

4.7 ± 4%

b,d

48.7 ± 6%

33.12 ± 1.89 98 ± 1%

25.88 ± 1.56

Note: (1) n = 6 represents the number of samples, and the statistical significance was analyzed by the using GraphPad (Prism 5) software
spearmann correlation test, (2) DCF fluorescence compared with the (+) control represents the H2O2 treated cells and (–) control indicate the treatment of cells with 0.1% DMSO (the solvent of OE) containing DMEM, respectively and averaged values of ROS intensity
for at least 100 cells from each coverslip (n = 6).
a
P < 0.0001 indicates a significant difference compared with the (+) control group of Ros intensity.
b
P < 0.0001 indicates a significant difference compared with the (+) control group of apoptosis rate.
c
P < 0.0001 indicates a significant difference compared with the (–) control group of Ros intensity.
d
P < 0.0001 indicates a significant difference compared with the (–) control group of apoptosis rate.
* P < 0.05 indicates a significant correlation compared with the OE IC50 group of apoptosis rate
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Figure 4. Cellular ROS detection was done by DCFDA assay a. DCF-I values of A549 lung cancer, b. DCF-I values of MIA PaCa pancreas cancer, c. DCF-I values of HUVEC endothelial cell lines were treated with IC50 values of O. onites essential oil as 4.79 µg/mL;
14.37 µg/mL; 67.06 µg/mL for 24 h on cells in an incubator. Then, DCFDA assay was performed at the indicated concentrations of O.
onites essential oil. DCF-I: Averaged values of ROS intensity for at least 100 cells from each coverslip (n = 6). Fluorescence cellular ROS
intensity was detected by Carl-Zeiss/Axio Observer 3, Zen 2.3 Blue Edition software. Production of cellular ROS intensity was compared against the nontreated control group. Used one-way analysis of variance (ANOVA), and then performed Tukey’s multiple comparison test to test statistical significance (*** P < 0.0001 indicates a significant difference compared with the (–) control group, n = 6).

headache, toothache, tachycardia, flu, bronchitis, gastrointestinal diseases, respiratory tract diseases, hypertension,
immunogenic, antiemetic and carminative (Bulut and
Tuzlaci, 2013; Polat and Satil, 2012; Sağıroğlu et al., 2013;
Sargin et al., 2013)in Turkish ethnobotanical studies. The
antioxidant effects of flavonoids from O. onites have been
investigated previously. Hazzit et al. (2006) revealed that

the O. onites distillate has beneficial effects on the antioxidant status, lipid profile and flow- and nitroglycerinemediated dilatation of the brachial artery in patients with
mild hyperlipidemia.
There are reports of orally administered Origanum spp.
regarding potential safety and efficacy against colorectal
cancer. Both Spyridopoulou et al. (2019) and Llana-Ruiz-
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Figure 5. Representative microscope images from DCFDA assay. OE IC50 Magnification: 10×, Control Magnification:
40× A549 cells (4.79 µg/mL for 24 h). Arrows point to apoptotic cells, arrowheads point to nonapoptotic cells.

Cabello et al. (2017) reported that oral administration
at a dose of 370 mg/kg OE on BALB/c for 13 days mice
(Spyridopoulou et al., 2019) and at a dose of 200 mg/kg
O. vulgare L. subsp. virens (Hoffmanns. & Link) Ietsw. in
Wistar rats for 90 days did not cause toxic effects (LlanaRuiz-Cabello et al., 2017). An in vitro study suggested that
inhibition of the growth was slightly time-dependent since
a reduction in the viability of HepG2 cells from 57.48 µg/
mL doses and IC50 was around 76.64 µg/mL after 24 h exposure by O. onites (Sivas and Tomsuk, 2011). In another
report, Özkan and Erdoğan ( 2011) suggested that the essential oil of O. onites decreased HepG2 cell viability at
higher concentrations (>149.12 μg/mL).
However, systemic administration of O. onites may also
affect other cell types. For example, the possible effects
of this drug on other cell types (e.g., cancer, fibroblast,
or endothelial cell lines) has not been widely studied. In
this study, we investigated some physiological effects of O.
onites essential oil on A549 lung cancer, MIA PaCa pancreas cancer, and HUVEC endothelial cell lines. Our findings
clearly show that O. onites treatment at 9.58–191.6 µg/mL
concentrations can inhibit cell proliferation in a cell-type
(A549 and MIA PaCa) dependent fashion. These observations imply that O. onites administration may impact the
process of wound healing. Although, this subject has yet to
be investigated; clarification of molecular mechanisms underlying this observation can have important clinical and
pharmacological implications. As shown in Figure 4, we
also demonstrated that O. onites at IC50 values can exert inhibitory effects on the migration rate of the entire cell lines
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tested in this study. Especially, the A549 lung cancer cell
line was amongst the most sensitive to O. onites treatment.
These findings suggest that O. onites administration may
have implications in cancer cellular migratory processes
such as wound healing or cellular extravasation. Although
underlying molecular mechanisms remain elusive, Spyridopoulou et al. (2019) showed that oral administration
of OE significantly inhibited the growth of CT26 tumors
in BALB/c mice. The essential oil of O. vulgare L has also
been tested in vivo tumor models. Misharina et al. (2013)
reported that formation and the growth of engrafted Lewis
carcinoma tumors were inhibited with O. vulgare oil by
oral administration to F1 DBA C57 black hybrid mice.
O. onites-induced decrease in cell migration rates might
be due to the reduced proliferative capacity upon O. onites
treatment. To our knowledge, Spyridopoulou et al. (2019)
is the only report of the OE-induced cancer cell migration inhibition for now. Bostancıoğlu et al. (2012) described the effects of OE on RATEC cells by antimigratory. It
has been reported that different Origanum species extracts have antimigration effects in cancer cells. For example
methanolic or the ethanolic extract of Origanum syriacum
L. against LoVo and SW620 human colon cancer (Aldisi et
al., 2019) or MDA-MB-231 human breast cancer cell lines
(Al Kahlout and Eid, 2014). Also, the ethanolic extract of
Origanum majorana was reported to reduce the migration
rate of the MDA-MB-231 cancer cell line (Al Dhaheri et
al., 2013). Carvacrol which is the principal component of
Origanum spp., Andoğan et al. (2002) reported inhibiting
the in vitro migration of various human cancer cells (Dai
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Figure 6. Migration rates were decreased significantly. a. A549 lung cancer (24 h by 64 ± 6%, 48 h 67 ± 4% for A549), b. MIA PaCa pancreas cancer (24 h 49 ± 2%, 48 h 69 ± 4% for MIA PaCa), c. HUVEC endothelial (24 h 47 ± 5%, 48 h 70 ± 1% for HUVEC). In an incubator, the cell line was treated with O. onites essential oil at IC50 concentration for 24 and 48 h. Scratch determinations were performed
24 and 48 h after treatment with the indicated concentration of O. onites essential oil. The 24- and 48-h mobility (the time the gap was
closed) was calculated by measuring the gap at 0 and 24/48 h after scraping the board. The percentage change in the migration rate was
compared with the untreated control group, and one-way analysis of variance was used, followed by Tukey’s multiple comparison test
(*** P < 0.0001, n = 3) to test for statistical significance.

et al., 2016; Fan et al., 2015; Jung et al., 2018; Trindade et
al., 2019).
It has been reported that extracts of different Origanum
species and carvacrol induce apoptosis and cell death in
different colon cancer cell lines in vitro (Fan et al., 2015).

While the carvacrol effects were studied by Matluobi et
al. (2018) on HUVEC and hMSC (human mesenchymal
stem cells), Rajput et al. (2017) studied it on human cancer
cell line HCT-12 (colon cancer) and MIA PaCa (pancreatic cancer). Also Khan et al. (2018) (on A549) and Jaafari
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Figure 7. Representative microscope images from in vitro scratch assay (Magnification 10×). a. 0 h A549 cells, b. 24 h
0µg/mL O. onites essential oil A549 cells (control for 24 h), c. 24 h 4.79 µg/mL OE A549 cells, d. 48 h 0 µg/mL OE A549
cells (control for 48 h), e. 48 h 14.37 µg/mL OE A549 cells, f. 0 h MIA PaCa cells, g. 24 h 0 µg/mL OE MIA PaCa cells
(control for 24 h), h. 24 h 14.37 µg/mL OE MIA PaCa cells, i. 48 h 0 µg/mL OE MIA PaCa cells (control for 48 h), j. 48 h
1.916 µg/mL OE MIA PaCa cells, k. 0 h HUVEC cells, l. 24 h 0 µg/mL OE HUVEC cells (control for 24 h), m. 24 h 67.06
µg/mL OE HUVEC cells, n. 48 h 0 µg/mL OE HUVEC cells (control for 48 h), o. 48 h 306.56 µg/mL OE HUVEC cells.
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et al. (2012) (on P-815, K-562, CEM, MCF-7 and MCF-7
gem) have studied the effects of carvacrol, and in addition
used anticancer drugs as the known compound to show
their anticancer activity in their studies. Spyridopoulou et
al. (2019) expressed that OE induces morphological changes usually observed in apoptosis both in the CT26 and
HT-29 cells. It was revealed that three concentrations (125,
250, and 500 µg/mL) of OE can significantly inhibit cell viability and induce 5RP7 cell apoptosis, and can also block
the formation and migration of rat adipose tissue endothelial cells (RATEC) in vitro. Because this essential oil has
much weaker cytotoxicity to endothelial cells, but it has
a strong effect on cancer cells (Bostancıoğlu et al., 2012)
Natural products are generally a very valuable source of
new anticancer compounds (Cragg and Newman, 2005).
The essential oils of certain plants are a mixture of certain biologically active compounds and may be the basis for
the identification of new anticancer molecules that can
be further used in therapeutics (Fitsiou et al., 2016). Our
results show that the efficacy of OE against proliferation
against A549 human lung cancer, MIA PaCahuman pancreas cancer can be attributed in part to apoptosis-related
mechanisms, making OE candidate for further research.
Thus, further tests should be performed to clarify
whether or not the effect of O. onites on cellular migration
is independent of the proliferation rate. These observations point to a possibility that low-concentration O. onites
treatment can reduce proliferation and cell migration rates
in certain types of cancer cells. However, we could not find
any reports investigating the possible link between lung or
pancreas cancer and O. onites treatment. Thus, further experimental and clinical studies are required to investigate
this hypothesis.
The effect of drugs on cancer cells can be achieved by
inducing cell apoptosis or necrosis or by causing changes
in cell morphology.
In different colon cancer cell lines extracts from different Origanum species have been reported to induce apoptotic cell death (Fan et al., 2015; Spyridopoulou et al.,
2019). In this study, it was found that as the treatment time
increased and the concentration of essential oil in O. onites
oil increased, the cell growth conditions were changed,
and the cell growth and apoptosis were inhibited to varying degrees.
The production of ROS is an important mediator of
many anticancer drugs (Trachootham et al., 2009). Previous studies have shown that ROS generated by chemotherapy is essential for inducing apoptosis in certain cancers (Simon et al., 2000). To our knowledge, this is the
first study of correlating OE induced apoptosis in A549
and HUVEC cell lines also correlated with ROS produce.
Here, we found that the ROS accumulation induced by OE
is related to the apoptosis of A549 and HUVEC cell lines.

Besides, OE made from natural plant materials may have
multiple targets that affect cancer cells. According to our
current research, ROS is one of the main points, but there
may still be other functional goals. The role of essential oils
may vary depending on the incubation period or the concentration of specific components or several components
tested in a complex mixture of O. onites oil essential oils.
Therefore, we recommend something like Spyridopoulou
et al. (2019). future research should focus on investigating
whether the antiproliferative activity of O. onites oil on human cancer cells can be attributed to its main components
and determine whether there is a synergistic interaction
between them.
Based on these results, it is proved that OE has an anticancer effect. The observed cytotoxic effects of OE may
be due to the presence of specific components or several
components in the complex mixture of OE. These findings may be a prerequisite for the potential development
of these bioactive substances as effective antitumor drugs.
However, further research is needed to evaluate its toxicity and safety. Also, these data can pave the way for the
future development of anticancer treatment opportunities.
This preliminary study will be expanded by implementing
different cell lines. Even so, to better understand the OE
effect, further in vivo studies are still needed.
5. Conclusion
Although further tests are required to confirm our conclusions, our preliminary in vitro observations imply that OE
administration may alter processes of cellular proliferation, apoptosis and cellular migration in a cell line- and
dose-dependent manner. Therefore, OE treatment can
potentially impact cellular processes such as wound healing or cellular extravasation. Moreover, proliferative and
metastatic properties of certain cancer cells can also be
potentially altered in response to OE treatment in a cell
type and dose-dependent fashion. O. onites essential oils
show promising anticancer effects. The results obtained
provide an experimental basis for reporting that OE leads
to cell death mainly through the process of apoptosis. The
observed cytotoxic effects of OE may be due to the presence of specific components or several components in the
complex mixture of OE.
Acknowledgments
The authors thank to DÜAGEM (Altınbaş University
Natural Products Research and Development Center) and
BİTEM (Bezmialem University Phytotherapy Education
Research and Application Center).

169

GÜNDOĞAN and ÖZDEMİR NATH / Turk J Bot
References
Abdel-Massih RM, Fares R, Bazzi S, El-Chami N, Baydoun E (2010).
The apoptotic and anti-proliferative activity of Origanum majorana extracts on human leukemic cell line. Leukemia Research 34 (8): 1052-1056. doi: 10.1016/j.leukres.2009.09.018

Fan K, Li X, Cao Y, Qi H, Li L et al. (2015). Carvacrol inhibits
proliferation and induces apoptosis in human colon cancer cells. Anti-Cancer Drugs 26 (8): 813-823. doi: 10.1097/
CAD.0000000000000263

Al Dhaheri Y, Attoub S, Arafat K, AbuQamar S, Viallet J et al. (2013).
Anti-metastatic and anti-tumor growth effects of Origanum
majorana on highly metastatic human breast cancer cells:
Inhibition of NFκB signaling and reduction of nitric oxide
production. PLoS ONE 8 (7): e68808. doi: 10.1371/journal.
pone.0068808

Fitsiou E, Mitropoulou G, Spyridopoulou K, Tiptiri-Kourpeti A,
Vamvakias M et al. (2016). Phytochemical profile and evaluation of the biological activities of essential oils derived from the
Greek aromatic plant species Ocimum basilicum, Mentha spicata, Pimpinella anisum and Fortunella margarita. Molecules
21 (8): 1069. doi: 10.3390/molecules21081069

Al Kahlout A, Eid A (2014). Aqueous extract of Origanum syriacum
inhibits proliferation, migration, adhesion as well as erk1/2
phosphorylation in aggressive breast cancer. In: Qatar Foundation Annual Research Conference; Qatar, Doha. doi: 10.5339/
qfarc.2014.HBSP1103

Hazzit M, Baaliouamer A, Faleiro ML, Miguel MG (2006). Composition of the essential oils of Thymus and Origanum species
from Algeria and their antioxidant and antimicrobial activities.
Journal of Agricultural and Food Chemistry 54 (17): 63146321. doi: 10.1021/jf0606104

Aldisi SS, Jaganjac M, Eid AH, Goktepe I (2019). Evaluation of apoptotic, antiproliferative, and antimigratory activity of Origanum syriacum against metastatic colon cancer cells. Journal of Herbs, Spices & Medicinal Plants 25 (3): 202-217. doi:
10.1080/10496475.2019.1587674
Al-Kalaldeh JZ, Abu-Dahab R, Afifi FU (2010). Volatile oil composition and antiproliferative activity of Laurus nobilis, Origanum
syriacum, Origanum vulgare, and Salvia triloba against human
breast adenocarcinoma cells. Nutrition Research 30 (4): 271278. doi: 10.1016/j.nutres.2010.04.001

Jaafari A, Tilaoui M, Mouse HA, M’Bark LA, Aboufatima R et al.
(2012). Comparative study of the antitumor effect of natural monoterpenes: relationship to cell cycle analysis. Brazilian Journal of Pharmacognosy 22 (3): 534-540. doi: 10.1590/
S0102-695X2012005000021
Jiang H, Ren Y, Zhao J, Feng J (2004). Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced
apoptosis. Human Molecular Genetics 13 (16): 1745-1754. doi:
10.1093/hmg/ddh180

Andoğan BC, Baydar H, Kaya S, Demirci M, Özbaşar D et al. (2002).
Antimicrobial activity and chemical composition of some essential oils. Archives of Pharmacal Research 25 (6): 860-864.
doi: 10.1007/BF02977005

Jung CY, Kim SY, Lee C (2018). Carvacrol targets AXL to inhibit cell
proliferation and migration in non-small cell lung cancer cells.
Anticancer Research 38 (1): 279-286. doi: 10.21873/anticanres.12219

Baranauskaite J, Kubiliene A, Marksa M, Petrikaite V, Vitkevičius
K et al. (2017). The influence of different oregano species on
the antioxidant activity determined using HPLC postcolumn
DPPH method and anticancer activity of carvacrol and rosmarinic acid. BioMed Research International 2017: 1681392
doi: 10.1155/2017/1681392

Khan I, Bahuguna A, Kumar P, Bajpai VK, Kang SC (2018). In vitro
and in vivo antitumor potential of carvacrol nanoemulsion
against human lung adenocarcinoma A549 cells via mitochondrial mediated apoptosis. Scientific Reports 8 (1): 144. doi:
10.1038/s41598-017-18644-9

Bostancıoğlu RB, Kürkçüoğlu M, Başer KHC, Koparal AT (2012).
Assessment of anti-angiogenic and anti-tumoral potentials of
Origanum onites L. essential oil. Food and Chemical Toxicology 50 (6): 2002-2008. doi: 10.1016/j.fct.2012.03.074
Bulut G, Tuzlaci E (2013). An ethnobotanical study of medicinal
plants in Turgutlu (Manisa–Turkey). Journal of Ethnopharmacology 149 (3): 633-647. doi: 10.1016/j.jep.2013.07.016
Cragg GM, Newman DJ (2005). Plants as a source of anti-cancer
agents. Journal of Ethnopharmacology 100 (1-2): 72-79. doi:
10.1016/j.jep.2005.05.011
Dai W, Sun C, Huang S, Zhou Q (2016). Carvacrol suppresses proliferation and invasion in human oral squamous cell carcinoma.
Onco Targets and Therapy 9: 2297-2304. doi: 10.2147/OTT.
S98875
Ietswaart JH (1982). Origanum L. In: Davis PH (editor). Flora of
Turkey and the East Aegean Islands, Vol. 7. Edinburgh, UK:
Edinburgh University Press, pp. 308-309.

170

Larsen KE, Fon EA, Hastings TG, Edwards RH, Sulzer D (2002).
Methamphetamine-induced degeneration of dopaminergic
neurons involves autophagy and upregulation of dopamine
synthesis. Journal of Neuroscience 22 (20): 8951-8960. doi:
10.1523/jneurosci.22-20-08951.2002
Liang CC, Park AY, Guan JL (2007). In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nature Protocols 2 (2): 329-333. doi: 10.1038/
nprot.2007.30
Liu K, Liu P, Liu R, Wu X (2015). Dual AO/EB staining to detect
apoptosis in osteosarcoma cells compared with flow cytometry. Medical Science Monitor Basic Research 21: 15-20 doi:
10.12659/MSMBR.893327
Llana-Ruiz-Cabello M, Maisanaba S, Puerto M, Pichardo S, Jos A et
al. (2017). A subchronic 90-day oral toxicity study of Origanum vulgare essential oil in rats. Food and Chemical Toxicology 101: 36-47. doi: 10.1016/j.fct.2017.01.001

GÜNDOĞAN and ÖZDEMİR NATH / Turk J Bot
Loziene K, Venskutonis PR (2005). Influence of environmental and
genetic factors on the stability of essential oil composition of
Thymus pulegioides. Biochemical Systematics and Ecology 33
(5): 517-525 doi: 10.1016/j.bse.2004.10.004
Matluobi D, Araghi A, Maragheh BFA, Rezabakhsh A, Soltani S et
al. (2018). Carvacrol promotes angiogenic paracrine potential
and endothelial differentiation of human mesenchymal stem
cells at low concentrations. Microvascular Research 115: 20-27.
doi: 10.1016/j.mvr.2017.08.003
Misharina TA, Burlakova EB, Fatkullina LD, Alinkina ES, Vorob’eva
AK et al. (2013). Effect of Oregano essential oil on the engraftment and development of Lewis carcinoma in F1 DBA C57
black hybrid mice. Applied Biochemistry and Microbiology 49
(4): 432-436. doi: 10.7868/s0555109913040090
Mosmann T (1983). Rapid colorimetric assay for cellular growth
and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65 (1-2): 55-63. doi:
10.1016/0022-1759(83)90303-4
Novato TPL, Araújo LX, de Monteiro CMO, Maturano R, Senra T
de OS et al. (2015). Evaluation of the combined effect of thymol, carvacrol and (E)-cinnamaldehyde on Amblyomma sculptum (Acari: Ixodidae) and Dermacentor nitens (Acari: Ixodidae) larvae. Veterinary Parasitology 212 (3-4): 331-335. doi:
10.1016/j.vetpar.2015.08.021
Özkan A, Erdoğan A (2011). A comparative evaluation of antioxidant and anticancer activity of essential oil from Origanum
onites (Lamiaceae) and its two major phenolic components.
Turkish Journal of Biology 35 (6): 735-742. doi: 10.3906/biy1011-170
Pelicano H, Carney D, Huang P (2004). ROS stress in cancer cells and
therapeutic implications. In Drug Resistance Updates 7(2): 97110. doi: 10.1016/j.drup.2004.01.004
Polat R, Satil F (2012). An ethnobotanical survey of medicinal plants
in Edremit Gulf (Balıkesir–Turkey). Journal of Ethnopharmacology 139 (2): 626-641. doi: 10.1016/j.jep.2011.12.004
Qatar Al-Nada K Jssim, Abdul-Halim AG (2020). Cytotoxic effect of
synergism relationship of oil extract from Origanum majorana
L. and silicon nano particles on MCF-7. Plant Archives 20 (1):
817-821.
Rajput JD, Bagul SD, Bendre RS. (2017). Synthesis, biological activities and molecular docking simulation of hydrazone scaffolds
of carvacrol, thymol and eugenol. Research on Chemical Intermediates 43 (11): 6601-6616. doi: 10.1007/s11164-017-3007-3

Rojas-Armas JP, Arroyo-Acevedo JL, Palomino-Pacheco M, Herrera-Calderón O, Ortiz-Sánchez JM et al. (2020). The essential
oil of Cymbopogon citratus stapt and carvacrol: An approach
of the antitumor effect on 7,12-dimethylbenz-[α]-anthracene
(DMBA)-induced breast cancer in female rats. Molecules 25
(14): 3284. doi: 10.3390/molecules25143284
Sağıroğlu M, Dalgıccedil S, Toksoy S (2013). Medicinal plants used
in Dalaman (Muğla), Turkey. Journal of Medicinal Plants Research 7 (28): 2053-2066. doi: 10.5897/jmpr2013.2590
Sargin SA, Akçicek E, Selvi S (2013). An ethnobotanical study of medicinal plants used by the local people of Alaşehir (Manisa) in
Turkey. Journal of Ethnopharmacology 150 (3): 860-874. doi:
10.1016/j.jep.2013.09.040
Sari I, Donmez Arat G, Ozkan O, Aydemir I, Ozbey C et al. (2020).
Apoptotic and cytotoxic effect of Origanum minutiflorum on
NB2A neuroblastoma cells. Ankara Üniversitesi Eczacılık
Fakültesi Dergisi 44 (2): 281-292. doi: 10.33483/jfpau.707277
Simon HU, Haj-Yehia A, Levi-Schaffer F (2000). Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5 (5): 415418. dio: 10.1023/A:1009616228304
Sivas H, Tomsuk Ö (2011). Antiproliferative and apoptotic effects of
the essential oil of Origanum onites and carvacrol on Hep-G2
cells. Anadolu Üniversitesi Bilim ve Teknoloji Dergisi-C Yaşam
Bilimleri ve Biyoteknoloji 1 (2): 171-180.
Spyridopoulou K, Fitsiou E, Bouloukosta E, Tiptiri-Kourpeti A,
Vamvakias M et al. (2019). Extraction, chemical composition,
and anticancer potential of Origanum onites L. essential oil.
Molecules 24 (14): 2612. doi: 10.3390/molecules24142612
Trachootham D, Alexandre J, Huang P (2009). Targeting cancer
cells by ROS-mediated mechanisms: a radical therapeutic approach? Nature Reviews Drug Discovery 8 (7): 579-591. doi:
10.1038/nrd2803
Trindade GGG, Thrivikraman G, Menezes PP, França CM, Lima BS
et al. (2019). Carvacrol/β-cyclodextrin inclusion complex inhibits cell proliferation and migration of prostate cancer cells.
Food and Chemical Toxicology 125: 198-209. doi: 10.1016/j.
fct.2019.01.003
Vokou D, Kokkini S, BessiÈRe JM (1988). Origanum onites (Lamiaceae) in Greece: distribution, volatile oil yield, and composition.
Economic Botany 42 (3): 407-412. doi: 10.1007/BF02860163

171

